Table1.
Relationshipbetweenpositivityofantiphospholipidassaysandhistoryofthrombosis
| Thrombosis | Total | Oddsratio | 95%CI | Pvalue | |||
|---|---|---|---|---|---|---|---|
| Yes | No | ||||||
| aPT-A | Positive | 8 | 27 | 35 | 3.556 | 1.221–10.355 | 0.0278 |
| Negative | 8 | 96 | 104 | ||||
| aPS/PT | Positive | 8 | 22 | 30 | 4.591 | 1.555–15.560 | 0.0072 |
| Negative | 8 | 101 | 109 | ||||
| aβ2GPI/CL | Positive | 10 | 23 | 33 | 7.246 | 2.39–21.966 | 0.0005 |
| Negative | 6 | 100 | 106 | ||||
| IgGaCL | Positive | 5 | 12 | 17 | 4.204 | 1.250–14.148 | 0.0282 |
| Negative | 11 | 111 | 122 | ||||
| IgMaCL | Positive | 2 | 9 | 11 | 1.809 | 0.354–9.232 | 0.6158 |
| Negative | 14 | 114 | 128 | ||||
| LAC | Positive | 7 | 9 | 16 | 9.852 | 2.972–32.657 | 0.0004 |
| Negative | 9 | 114 | 123 | ||||
aPT-A, antiprothrombin antibody measured using high binding plates; aPS/PT, antiphosphatidylserine/prothrombin antibody; aβ2GPI/CL, β2-glycoprotein I dependent anticardiolipin antibody; aCL, anticardiolipin antibody; LAC, lupus anticoagulant